Indications and uses
Uses: Symptomatic treatment of common warts, verruca vulgaris, plantar's warts and flat warts.
Uses: Symptomatic treatment of common warts, verruca vulgaris, plantar's warts and flat warts.
Directions: Apply 3 times daily to affected area. Warts will dry and flake away over a 3-6 week period. Some individuals may be sensitive to essential oils. Skin test for tolerability. If irritation or reaction occurs, discontinue use.
Uses: Symptomatic treatment of common warts, verruca vulgaris, plantar's warts and flat warts.
Warnings: For external use only.
Do not use if tamper evident seal is broken.
Directions: Apply 3 times daily to affected area. Warts will dry and flake away over a 3-6 week period. Some individuals may be sensitive to essential oils. Skin test for tolerability. If irritation or reaction occurs, discontinue use.
Inactive Ingredients: Cedar Leaf Oil, Melaleuca Alternifolia Leaf Oil, Ricinus Communis Seed Oil.
Questions? Comments?
www.naturasil.com 866.371.2499 Mfd.
by: Nature's Innovation, Inc. 2723 Brickton North Dr., Buford, GA
30518 Not tested on animals.
Purpose
Wart Symptom Relief
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10893-687-30 | 2020-02-04 | C162847 | 48780-1 | 9d75b9d0-00ca-f424-e053-dadaa90a57ce | Warts 30 ml Labeling |
| 10893-687-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-00ca-f424-e053-dadaa90a57ce | Warts 30 ml Labeling |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE INGREDIENT | 1NT28V9397 | 1 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE MOIETY | 1NT28V9397 | 1 | |
| CASTOR OIL | INACTIVE INGREDIENT | D5340Y2I9G | 1 | |
| CEDAR LEAF OIL | INACTIVE INGREDIENT | BJ169U4NLG | 1 | |
| TEA TREE OIL | INACTIVE INGREDIENT | VIF565UC2G | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10893-687 | 10893-687-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| THUJA OCCIDENTALIS LEAFY TWIG | 1NT28V9397 | ACTIB |
| CEDAR LEAF OIL | BJ169U4NLG | IACT |
| TEA TREE OIL | VIF565UC2G | IACT |
| CASTOR OIL | D5340Y2I9G | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, EXTENDED RELEASE / ORAL | 23.27 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | GEL / NASAL | 429 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | GRANULE, FOR SUSPENSION / ORAL | 128 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | INJECTION, SOLUTION / INTRAMUSCULAR | 525 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET / ORAL | 17 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | CAPSULE, EXTENDED RELEASE / ORAL | 47 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | EMULSION / OPHTHALMIC | 32 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | SPRAY / NASAL | NA | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, FILM COATED / ORAL | 15.29 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | OINTMENT / TOPICAL | 14.9 %w/w | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | SOLUTION / TOPICAL | 1.38 %w/w | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | INJECTION / INTRAMUSCULAR | 885 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | CAPSULE / ORAL | 1.04 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET / SUBLINGUAL | 1.6 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b4427511-4a39-4051-97ff-b7bdc63ca3a8 | f658153c-95a0-4d2b-8f17-f03b683d71d2 | 2011-10-01 | Warnings | b4427511-4a39-4051-97ff-b7bdc63ca3a8 f658153c-95a0-4d2b-8f17-f03b683d71d2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.